Last reviewed · How we verify

NCT06279416

Expected Difficult Airway Management

Completed Last updated 15 January 2025
What this trial tests

trial testing fiberoptic intubation in Awake Intubation in 49 participants. Completed in 30 December 2024.

Timeline
30 December 2023
Primary endpoint
30 December 2024
30 December 2024

Quick facts

Lead sponsorKocaeli City Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment49
Start date30 December 2023
Primary completion30 December 2024
Estimated completion30 December 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kocaeli City Hospital

Who can join

18 and older, any sex, with Awake Intubation or Advanced Airway Techniques. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the investigators will evaluate the advanced airway methods applied in the anesthesiology and reanimation clinic of the hospital to patients who met the criteria for awake intubation specified in the ASA 2022 difficult airway management guideline or who could not be intubated after induction of anesthesia in another center. The advanced airway method applied to the difficult airway patient expected in the operating room, the duration, success and complications of the method will be observed and recorded.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Supraglottic airway devices in awake tracheal intubation: a viable alternative to fiberoptic and video laryngoscopy.
    Yilmaz M, Yuksek A, Civraz AZT, Kara MY, et al · · 2025 · PMID 41057781 · DOI 10.1186/s12871-025-03331-4

Verify or expand the search:

Other Kocaeli City Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06279416.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing